258 related articles for article (PubMed ID: 12975472)
1. CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis.
Sancho D; Gómez M; Viedma F; Esplugues E; Gordón-Alonso M; García-López MA; de la Fuente H; Martínez-A C; Lauzurica P; Sánchez-Madrid F
J Clin Invest; 2003 Sep; 112(6):872-82. PubMed ID: 12975472
[TBL] [Abstract][Full Text] [Related]
2. CD69: an unexpected regulator of TH17 cell-driven inflammatory responses.
Martín P; Sánchez-Madrid F
Sci Signal; 2011 Mar; 4(165):pe14. PubMed ID: 21427408
[TBL] [Abstract][Full Text] [Related]
3. CD69 targeting differentially affects the course of collagen-induced arthritis.
Sancho D; Gómez M; Martinez Del Hoyo G; Lamana A; Esplugues E; Lauzurica P; Martinez-A C; Sánchez-Madrid F
J Leukoc Biol; 2006 Dec; 80(6):1233-41. PubMed ID: 16921025
[TBL] [Abstract][Full Text] [Related]
4. The role of CD69 in acute neutrophil-mediated inflammation.
Lamana A; Sancho D; Cruz-Adalia A; del Hoyo GM; Herrera AM; Feria M; Díaz-González F; Gómez M; Sánchez-Madrid F
Eur J Immunol; 2006 Oct; 36(10):2632-8. PubMed ID: 16983725
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumor immunity in mice deficient in CD69.
Esplugues E; Sancho D; Vega-Ramos J; Martínez C; Syrbe U; Hamann A; Engel P; Sánchez-Madrid F; Lauzurica P
J Exp Med; 2003 May; 197(9):1093-106. PubMed ID: 12732655
[TBL] [Abstract][Full Text] [Related]
6. Inflammation-induced CD69
Zhang X; Jiang Z; Gu Y; Liu Y; Cao X; Han Y
Sci China Life Sci; 2016 Dec; 59(12):1259-1269. PubMed ID: 27933593
[TBL] [Abstract][Full Text] [Related]
7. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of Murine Collagen-Induced Arthritis by Targeting CD6.
Li Y; Ruth JH; Rasmussen SM; Athukorala KS; Weber DP; Amin MA; Campbell PL; Singer NG; Fox DA; Lin F
Arthritis Rheumatol; 2020 Sep; 72(9):1505-1513. PubMed ID: 32307907
[TBL] [Abstract][Full Text] [Related]
9. Torilin ameliorates type II collagen-induced arthritis in mouse model of rheumatoid arthritis.
Endale M; Lee WM; Kwak YS; Kim NM; Kim BK; Kim SH; Cho J; Kim S; Park SC; Yun BS; Ko D; Rhee M
Int Immunopharmacol; 2013 Jun; 16(2):232-42. PubMed ID: 23623942
[TBL] [Abstract][Full Text] [Related]
10. Loss of Smad7 Promotes Inflammation in Rheumatoid Arthritis.
Zhou G; Sun X; Qin Q; Lv J; Cai Y; Wang M; Mu R; Lan HY; Wang QW
Front Immunol; 2018; 9():2537. PubMed ID: 30450102
[No Abstract] [Full Text] [Related]
11. CD69 limits early inflammatory diseases associated with immune response to Listeria monocytogenes infection.
Vega-Ramos J; Alari-Pahissa E; Valle JD; Carrasco-Marín E; Esplugues E; Borràs M; Martínez-A C; Lauzurica P
Immunol Cell Biol; 2010 Oct; 88(7):707-15. PubMed ID: 20440294
[TBL] [Abstract][Full Text] [Related]
12. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
[TBL] [Abstract][Full Text] [Related]
13. Remission of collagen-induced arthritis is associated with high levels of transforming growth factor-beta expression in the joint.
Marinova-Mutafchieva L; Gabay C; Funa K; Williams RO
Clin Exp Immunol; 2006 Nov; 146(2):287-93. PubMed ID: 17034581
[TBL] [Abstract][Full Text] [Related]
14. CD69-null mice protected from arthritis induced with anti-type II collagen antibodies.
Murata K; Inami M; Hasegawa A; Kubo S; Kimura M; Yamashita M; Hosokawa H; Nagao T; Suzuki K; Hashimoto K; Shinkai H; Koseki H; Taniguchi M; Ziegler SF; Nakayama T
Int Immunol; 2003 Aug; 15(8):987-92. PubMed ID: 12882836
[TBL] [Abstract][Full Text] [Related]
15. CD69 is a TGF-β/1α,25-dihydroxyvitamin D3 target gene in monocytes.
Wöbke TK; von Knethen A; Steinhilber D; Sorg BL
PLoS One; 2013; 8(5):e64635. PubMed ID: 23696902
[TBL] [Abstract][Full Text] [Related]
16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression.
Cortés JR; Sánchez-Díaz R; Bovolenta ER; Barreiro O; Lasarte S; Matesanz-Marín A; Toribio ML; Sánchez-Madrid F; Martín P
J Autoimmun; 2014 Dec; 55():51-62. PubMed ID: 24934597
[TBL] [Abstract][Full Text] [Related]
18. Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA).
Müssener A; Litton MJ; Lindroos E; Klareskog L
Clin Exp Immunol; 1997 Mar; 107(3):485-93. PubMed ID: 9067522
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation.
Iwai H; Kozono Y; Hirose S; Akiba H; Yagita H; Okumura K; Kohsaka H; Miyasaka N; Azuma M
J Immunol; 2002 Oct; 169(8):4332-9. PubMed ID: 12370365
[TBL] [Abstract][Full Text] [Related]
20. CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.
Han Y; Guo Q; Zhang M; Chen Z; Cao X
J Immunol; 2009 Jan; 182(1):111-20. PubMed ID: 19109141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]